Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A and Hyaluronic Acid in Dry Eye Syndrome
NCT06936462Completed
- Sponsor
- Hallym University Kangnam Sacred Heart Hospital
- Start
- Jan 2020
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Randomised, double-blind trial of CyclAGel in dry eye syndrome (DED) (2 arms), sponsored by Hallym University Kangnam Sacred Heart Hospital. Primary endpoint: Ocular Surface Microbiome Composition at 12 weeks. Started Jan 2020; status: completed.
02
Drugs
CyclAGel
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06936462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06936462.